The Relevance of State Laws Regulating Opioid Prescribing for People Living With Serious Illness
Published by Elsevier Inc..
CONTEXT: Opioids are commonly used to relieve symptoms such as pain and dyspnea in people living with serious illness. In recent years, 36 states enacted limitations for opioid prescriptions to mitigate the impact of the opioid overdose crisis. Palliative care clinicians have been vocal about the unintended consequences of opioid policies, yet little is known about how state policies apply to opioid prescribing in non-cancer-related serious illness.
OBJECTIVE: To summarize current state-level limitations to opioid prescribing and exemptions relevant to people living with non-cancer-related serious illness.
METHODS: Investigators searched publicly available laws ("[state] + opioid legislation") to extract information on opioid prescribing and exemptions. Laws were examined for application to palliative care, hospice, non-cancer-related serious illness, and language about specific symptoms was documented when applicable (e.g., pain, dyspnea).
RESULTS: Most state laws focused on acute pain and/or initial opioid prescriptions. Thirty-three of the thirty-six states with opioid-limiting legislation exempt situations applicable to people living with non-cancer-related serious illness. Three states did not have any exemptions relevant to people living with non-cancer-related serious illness.
DISCUSSION: The results indicate that while most states recognize the importance of timely opioid access for palliation of pain, clinically relevant exemptions for people living with non-cancer-related serious illness may be lacking. When present, language describing palliative care, hospice, and terminal illness exemptions is often broad and may generate confusion between primary and specialty palliative care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
Journal of pain and symptom management - 64(2022), 2 vom: 10. Aug., Seite 89-99 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jones, Katie Fitzgerald [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.07.2022 Date Revised 10.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jpainsymman.2022.05.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340848979 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340848979 | ||
| 003 | DE-627 | ||
| 005 | 20231226010416.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jpainsymman.2022.05.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1136.xml |
| 035 | |a (DE-627)NLM340848979 | ||
| 035 | |a (NLM)35561937 | ||
| 035 | |a (PII)S0885-3924(22)00705-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jones, Katie Fitzgerald |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Relevance of State Laws Regulating Opioid Prescribing for People Living With Serious Illness |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.07.2022 | ||
| 500 | |a Date Revised 10.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a CONTEXT: Opioids are commonly used to relieve symptoms such as pain and dyspnea in people living with serious illness. In recent years, 36 states enacted limitations for opioid prescriptions to mitigate the impact of the opioid overdose crisis. Palliative care clinicians have been vocal about the unintended consequences of opioid policies, yet little is known about how state policies apply to opioid prescribing in non-cancer-related serious illness | ||
| 520 | |a OBJECTIVE: To summarize current state-level limitations to opioid prescribing and exemptions relevant to people living with non-cancer-related serious illness | ||
| 520 | |a METHODS: Investigators searched publicly available laws ("[state] + opioid legislation") to extract information on opioid prescribing and exemptions. Laws were examined for application to palliative care, hospice, non-cancer-related serious illness, and language about specific symptoms was documented when applicable (e.g., pain, dyspnea) | ||
| 520 | |a RESULTS: Most state laws focused on acute pain and/or initial opioid prescriptions. Thirty-three of the thirty-six states with opioid-limiting legislation exempt situations applicable to people living with non-cancer-related serious illness. Three states did not have any exemptions relevant to people living with non-cancer-related serious illness | ||
| 520 | |a DISCUSSION: The results indicate that while most states recognize the importance of timely opioid access for palliation of pain, clinically relevant exemptions for people living with non-cancer-related serious illness may be lacking. When present, language describing palliative care, hospice, and terminal illness exemptions is often broad and may generate confusion between primary and specialty palliative care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Opioid analgesic | |
| 650 | 4 | |a health policy | |
| 650 | 4 | |a opioid prescription | |
| 650 | 4 | |a pain management | |
| 650 | 4 | |a palliative care | |
| 650 | 4 | |a serious illness | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 700 | 1 | |a Abdulhay, Lindsay Bell |e verfasserin |4 aut | |
| 700 | 1 | |a Orris, Steve R |e verfasserin |4 aut | |
| 700 | 1 | |a Merlin, Jessica S |e verfasserin |4 aut | |
| 700 | 1 | |a Schenker, Yael |e verfasserin |4 aut | |
| 700 | 1 | |a Bulls, Hailey W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pain and symptom management |d 1991 |g 64(2022), 2 vom: 10. Aug., Seite 89-99 |w (DE-627)NLM012642509 |x 1873-6513 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2022 |g number:2 |g day:10 |g month:08 |g pages:89-99 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jpainsymman.2022.05.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2022 |e 2 |b 10 |c 08 |h 89-99 | ||